This game changing milestone allows the Company to initiate its US based Phase 1b clinical study to evaluate the poten SAN DIEGO, November 12, 2024--Revelation Biosciences, Inc. (NASDAQ ...
This game changing milestone allows the Company to initiate its US based Phase 1b clinical study to evaluate the poten SAN DIEGO, November 12, 2024--Revelation ... for March 17-19, 2023 to be ...